Please provide your email address to receive an email when new articles are posted on . Although active surveillance is acceptable for low-risk prostate cancers, the strategy may be risky for patients ...

Pet Therapy: How the Cat I Never Wanted Saved My Life Malone et al 1 performed a randomized trial comparing 6 months of neoadjuvant versus adjuvant androgen deprivation therapy (ADT) combined with ...

CHICAGO -- Adding a short course of androgen deprivation therapy (ADT) to dose-escalated radiotherapy (RT) led to a mixed bag of outcomes in intermediate-risk prostate cancer, according to a large ...

March 4, 2010 — The results of a landmark study often represent the definitive word clinically. For the landmark Radiation Therapy Oncology Group (RTOG) 94-08 study, which evaluated short-term hormone ...

The rate of active surveillance as initial treatment increased from 2.0% in 2010 to 8.6% in 2020. The use of active surveillance in patients with intermediate-risk prostate cancer has increased in ...

Survival curves separated as early as 4 to 5 years after initiation of active surveillance or active treatment, investigators reported. Active surveillance (AS) should be cautiously offered to men ...

Robert De Niro, Warren Buffett and Ben Stiller had prostate cancer, detected at an early-enough stage to allow for recovery. Their treatments included surgery and radiation -- which may sometimes ...

ARLINGTON, Va., September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five ...

Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...

Adding external-beam radiation to brachytherapy does not improve 5-year freedom from progression (FFP) for men with intermediate-risk prostate cancer, but it does increase treatment toxicity. The ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk prostate cancer treated with external-beam radiation therapy (EBRT), ...